These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19482589)

  • 1. Immunomodulation by genetically engineered lactic acid bacteria.
    Van Huynegem K; Loos M; Steidler L
    Front Biosci (Landmark Ed); 2009 Jun; 14(13):4825-35. PubMed ID: 19482589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of gut-associated lymphoid tissue functions with genetically modified Lactococcus lactis.
    Rottiers P; De Smedt T; Steidler L
    Int Rev Immunol; 2009; 28(6):465-86. PubMed ID: 19954359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress on lactococcus lactis expressing heterologous antigens as live mucosal vaccines].
    Shi D; Song Y; Li YJ
    Wei Sheng Wu Xue Bao; 2006 Aug; 46(4):680-3. PubMed ID: 17037080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocontainment strategies for live lactic acid bacteria vaccine vectors.
    Lee P
    Bioeng Bugs; 2010; 1(1):75-7. PubMed ID: 21327129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically engineered Lactococcus lactis protect against house dust mite allergy in a BALB/c mouse model.
    Ai C; Zhang Q; Ren C; Wang G; Liu X; Tian F; Zhao J; Zhang H; Chen YQ; Chen W
    PLoS One; 2014; 9(10):e109461. PubMed ID: 25290938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.
    Steidler L; Hans W; Schotte L; Neirynck S; Obermeier F; Falk W; Fiers W; Remaut E
    Science; 2000 Aug; 289(5483):1352-5. PubMed ID: 10958782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review on Lactococcus lactis: from food to factory.
    Song AA; In LLA; Lim SHE; Rahim RA
    Microb Cell Fact; 2017 Apr; 16(1):55. PubMed ID: 28376880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production, secretion and purification of a correctly folded staphylococcal antigen in Lactococcus lactis.
    Samazan F; Rokbi B; Seguin D; Telles F; Gautier V; Richarme G; Chevret D; Varela PF; Velours C; Poquet I
    Microb Cell Fact; 2015 Jul; 14():104. PubMed ID: 26178240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a Lactococcus lactis ΔpyrG vaccine delivery platform expressing chromosomally integrated hly from Listeria monocytogenes.
    Bahey-El-Din M; Casey PG; Griffin BT; Gahan CG
    Bioeng Bugs; 2010; 1(1):66-74. PubMed ID: 21327128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology. Therapeutic manipulation of gut flora.
    Shanahan F
    Science; 2000 Aug; 289(5483):1311-2. PubMed ID: 10979858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.
    Parlane NA; Grage K; Lee JW; Buddle BM; Denis M; Rehm BH
    Appl Environ Microbiol; 2011 Dec; 77(24):8516-22. PubMed ID: 21984246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.
    Martín R; Chain F; Miquel S; Natividad JM; Sokol H; Verdu EF; Langella P; Bermúdez-Humarán LG
    Hum Vaccin Immunother; 2014; 10(6):1611-21. PubMed ID: 24732667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Strategies for Efficient Production and Delivery of Live Biotherapeutics and Biotechnological Uses of
    Tavares LM; de Jesus LCL; da Silva TF; Barroso FAL; Batista VL; Coelho-Rocha ND; Azevedo V; Drumond MM; Mancha-Agresti P
    Front Bioeng Biotechnol; 2020; 8():517166. PubMed ID: 33251190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of recombinant Lactococcus lactis expressing bovine beta-lactoglobulin partially prevents mice from sensitization.
    Adel-Patient K; Ah-Leung S; Creminon C; Nouaille S; Chatel JM; Langella P; Wal JM
    Clin Exp Allergy; 2005 Apr; 35(4):539-46. PubMed ID: 15836765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X; Xing Y; Guo L; Lv X; Song H; Xi T
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of lactic acid bacteria for delivery of therapeutic proteins and peptides.
    Plavec TV; Berlec A
    Appl Microbiol Biotechnol; 2019 Mar; 103(5):2053-2066. PubMed ID: 30656391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous protein production and delivery systems for Lactococcus lactis.
    Nouaille S; Ribeiro LA; Miyoshi A; Pontes D; Le Loir Y; Oliveira SC; Langella P; Azevedo V
    Genet Mol Res; 2003 Mar; 2(1):102-11. PubMed ID: 12917806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of peanut-induced allergic immune responses by oral lactic acid bacteria-based vaccines in mice.
    Ren C; Zhang Q; Wang G; Ai C; Hu M; Liu X; Tian F; Zhao J; Chen Y; Wang M; Zhang H; Chen W
    Appl Microbiol Biotechnol; 2014; 98(14):6353-64. PubMed ID: 24770368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities.
    Škrlec K; Ručman R; Jarc E; Sikirić P; Švajger U; Petan T; Perišić Nanut M; Štrukelj B; Berlec A
    Appl Microbiol Biotechnol; 2018 Dec; 102(23):10103-10117. PubMed ID: 30191288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting diseases with genetically engineered Lactococcus lactis and its course towards medical translation.
    Villatoro-Hernandez J; Montes-de-Oca-Luna R; Kuipers OP
    Expert Opin Biol Ther; 2011 Mar; 11(3):261-7. PubMed ID: 21204744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.